These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 13925166)

  • 21. [Experience in the intracavitary use of sarcolysin and thio-tepa in malignant ovarian tumors].
    ABBASOV AT
    Vopr Onkol; 1960; 6(4)():23-30. PubMed ID: 13791373
    [No Abstract]   [Full Text] [Related]  

  • 22. Thio-TEPA in treatment of metastatic cerebral malignancy.
    DAVIS PL; SHUMWAY MH
    JAMA; 1961 Feb; 175():714-5. PubMed ID: 13720230
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of triethylene thiophosphoramide (thio-TEPA) in the treatment of incurable neoplastic disease.
    LEVINE B
    J Chronic Dis; 1960 Aug; 12():258-64. PubMed ID: 14416250
    [No Abstract]   [Full Text] [Related]  

  • 24. Intracavitary thio-TEPA for malignant effusions.
    GROESBECK HP; CUDMORE JT
    Am Surg; 1962 Feb; 28():90-5. PubMed ID: 13902079
    [No Abstract]   [Full Text] [Related]  

  • 25. The effects of intravesical instillation of Thio-Tepa on the recurrence rate of bladder tumors.
    Asahi T; Matsumura Y; Tanahashi T; Yoshimoto J; Kaneshige T; Fujita Y; Ohmori H
    Acta Med Okayama; 1980 Feb; 34(1):43-9. PubMed ID: 6446839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Severe bone marrow damage after instillation of thio tepa into the bladder].
    Edgren B; Forsgren L; Boström H
    Nord Med; 1966 Apr; 75(17):481. PubMed ID: 4956156
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of malignant brain tumors with alkylating agents. Thio-TEPA (triethylene thiophosphoramide): its differential concentration and toxicity after arterial infusion.
    MARK VH; KJELLBERG RN; OJEMANN RG; SOLOWAY AH
    Neurology; 1960 Aug; 10():772-6. PubMed ID: 14421240
    [No Abstract]   [Full Text] [Related]  

  • 28. [On the problem of the treatment of oncogynecological patients with N,N',N"-triethylenethio-phosphoramide (thio-tepa)].
    MAIRANSAEV AKh
    Vopr Onkol; 1960; 6(4)():30-8. PubMed ID: 14420049
    [No Abstract]   [Full Text] [Related]  

  • 29. The prophylactic use of Thio-TEPA, an adjuvant in the treatment of bladder tumours.
    Dobrzecki W; Kaczmarek A
    Int Urol Nephrol; 1977; 9(2):145-9. PubMed ID: 412808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiosarcoma responsive to cyclophosphamide after failure of the combination of thio TEPA and methotrexate.
    GREENSPAN EM
    Cancer Chemother Rep; 1961 Apr; 11():147-55. PubMed ID: 13708350
    [No Abstract]   [Full Text] [Related]  

  • 31. Intravesical therapy of low stage bladder carcinoma with mitomycin C: comparison of results in untreated and previously treated patients.
    Prout GR; Griffin PP; Nocks BN; DeFuria MD; Daly JJ
    J Urol; 1982 Jun; 127(6):1096-8. PubMed ID: 6806488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of intravesical thio-tepa on normal and tumor urothelium.
    Nieh PT; Daly JJ; Heaney JA; Heney NM; Prout GR
    J Urol; 1978 Jan; 119(1):59-61. PubMed ID: 413937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Instillation of thio-tepa (Tifosyl) in vesical papillomatosis.
    Edsmyr F; Boman J
    Acta Radiol Ther Phys Biol; 1970 Oct; 9(5):395-400. PubMed ID: 4990891
    [No Abstract]   [Full Text] [Related]  

  • 34. [THE PRACTITIONER AND ANTINEOPLASTIC CHEMOTHERAPY. RECENT DATA].
    RAVINA A
    Presse Med (1893); 1965 Jan; 73():287-90. PubMed ID: 14230318
    [No Abstract]   [Full Text] [Related]  

  • 35. Unanticipated vesicoureteral reflux: a possible sequela of long-term thio-tepa instillations to the bladder.
    Mukamel E; Glanz I; Nissenkorn I; Cytron S; Servadio C
    J Urol; 1982 Feb; 127(2):245-6. PubMed ID: 6801270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of intravesical thio-tepa in the management of non-invasive carcinoma of the bladder.
    Koontz WW; Prout GR; Smith W; Frable WJ; Minnis JE
    J Urol; 1981 Mar; 125(3):307-12. PubMed ID: 6782251
    [No Abstract]   [Full Text] [Related]  

  • 37. Intravesical thio-tepa: a study of 3H-thymidine uptake in normal urothelium and FANFT-induced tumors in rats.
    Nieh PT; Daly JJ; Irwin RJ; Prout GR
    Invest Urol; 1979 May; 16(6):486-8. PubMed ID: 109416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of superficial bladder tumors in a controlled trial with thio-TEPA versus adriamycin.
    Horn Y; Eidelman A; Walach N; Yuval E; Markowitz A
    J Surg Oncol; 1984 Sep; 27(1):67-9. PubMed ID: 6434883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. THE TREATMENT OF ADVANCED CARCINOMA OF THE BLADDER.
    ROBERTS DI
    Br J Urol; 1965 Aug; 37():458-64. PubMed ID: 14346456
    [No Abstract]   [Full Text] [Related]  

  • 40. [Cell kinetics of the bladder carcinoma. II. Effects of thio-TEPA on proliferative kinetics of the cultured human bladder carcinoma cells (author's transl)].
    Kato T
    Nihon Hinyokika Gakkai Zasshi; 1976 Jul; 67(7):497-501. PubMed ID: 823357
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.